Background and Aim: Busulfan, is a bifunctional alkylating agent, commonly administered to children as a component of conditioning therapy prior to haematopoietic stem cell transplantation (HSCT). Dosing regimens vary from six hourly (QID) to once daily (OD) with individualisation of the dose considered standard practice as recommended within product information leaflets (PI)[1,2]. However, practices around […]
